CCL5 and neoplasm: In addition, according to the K–M analysis, positive CCL5 expression in the IC was associated with shorter RFS in the following subgroups: tumor stage 3 + 4 (p < 0.001), N0 (p = 0.030), N1/N2 (p = 0.039) and no chemotherapy (p < 0.001).